Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin ii-induced abdominal aortic aneurysms

Sean E. Thatcher, Xuan Zhang, Deborah A. Howatt, Frederique Yiannikouris, Susan Gurley, Terri Ennis, John A. Curci, Alan Daugherty, Lisa A. Cassis

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective-Angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II (AngII) to form angiotensin-(1-7) (Ang-(1-7)), which generally opposes effects of AngII. AngII infusion into hypercholesterolemic male mice induces formation of abdominal aortic aneurysms (AAAs). This study tests the hypothesis that deficiency of ACE2 promotes AngII-induced AAAs, whereas ACE2 activation suppresses aneurysm formation.

Approach and Results-ACE2 protein was detectable by immunostaining in mice and human AAAs. Whole-body deficiency of ACE2 significantly increased aortic lumen diameters and external diameters of suprarenal aortas from AngII-infused mice. Conversely, ACE2 deficiency in bone marrow-derived cells had no effect on AngII-induced AAAs. In contrast to AngII-induced AAAs, ACE2 deficiency had no significant effect on external aortic diameters of elastaseinduced AAAs. Because ACE2 deficiency promoted AAA formation in AngII-infused mice, we determined whether ACE2 activation suppressed AAAs. ACE2 activation by administration of diminazene aceturate (30 mg/kg per day) to Ldlr-/- mice increased kidney ACE2 mRNA abundance and activity and elevated plasma Ang-(1-7) concentrations. Unexpectedly, administration of diminazene aceturate significantly reduced total sera cholesterol and very low-density lipoprotein-cholesterol concentrations. Notably, diminazene aceturate significantly decreased aortic lumen diameters and aortic external diameters of AngII-infused mice resulting in a marked reduction in AAA incidence (from 73% to 29%). None of these effects of diminazene aceturate were observed in the Ace2-/y mice.

Conclusions-These results demonstrate that ACE2 exerts a modulatory role in AngII-induced AAA formation, and that therapeutic stimulation of ACE2 could be a benefit to reduce AAA expansion and rupture in patients with an activated renin-angiotensin system.

Original languageEnglish (US)
Pages (from-to)2617-2623
Number of pages7
JournalArteriosclerosis, thrombosis, and vascular biology
Volume34
Issue number12
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Abdominal Aortic Aneurysm
Angiotensins
Angiotensin II
Enzyme Activation
angiotensin converting enzyme 2
VLDL Cholesterol
Aortic Rupture
Renin-Angiotensin System
Bone Marrow Cells
Aneurysm
Aorta
Cholesterol

Keywords

  • Angiotensin converting enzyme 2
  • Angiotensin II
  • Aortic aneurysms, abdominal
  • Hypercholesterolemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin ii-induced abdominal aortic aneurysms. / Thatcher, Sean E.; Zhang, Xuan; Howatt, Deborah A.; Yiannikouris, Frederique; Gurley, Susan; Ennis, Terri; Curci, John A.; Daugherty, Alan; Cassis, Lisa A.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 34, No. 12, 01.01.2014, p. 2617-2623.

Research output: Contribution to journalArticle

Thatcher, Sean E. ; Zhang, Xuan ; Howatt, Deborah A. ; Yiannikouris, Frederique ; Gurley, Susan ; Ennis, Terri ; Curci, John A. ; Daugherty, Alan ; Cassis, Lisa A. / Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin ii-induced abdominal aortic aneurysms. In: Arteriosclerosis, thrombosis, and vascular biology. 2014 ; Vol. 34, No. 12. pp. 2617-2623.
@article{c4d05c6f08b342229cfb52066ee4d91b,
title = "Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin ii-induced abdominal aortic aneurysms",
abstract = "Objective-Angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II (AngII) to form angiotensin-(1-7) (Ang-(1-7)), which generally opposes effects of AngII. AngII infusion into hypercholesterolemic male mice induces formation of abdominal aortic aneurysms (AAAs). This study tests the hypothesis that deficiency of ACE2 promotes AngII-induced AAAs, whereas ACE2 activation suppresses aneurysm formation.Approach and Results-ACE2 protein was detectable by immunostaining in mice and human AAAs. Whole-body deficiency of ACE2 significantly increased aortic lumen diameters and external diameters of suprarenal aortas from AngII-infused mice. Conversely, ACE2 deficiency in bone marrow-derived cells had no effect on AngII-induced AAAs. In contrast to AngII-induced AAAs, ACE2 deficiency had no significant effect on external aortic diameters of elastaseinduced AAAs. Because ACE2 deficiency promoted AAA formation in AngII-infused mice, we determined whether ACE2 activation suppressed AAAs. ACE2 activation by administration of diminazene aceturate (30 mg/kg per day) to Ldlr-/- mice increased kidney ACE2 mRNA abundance and activity and elevated plasma Ang-(1-7) concentrations. Unexpectedly, administration of diminazene aceturate significantly reduced total sera cholesterol and very low-density lipoprotein-cholesterol concentrations. Notably, diminazene aceturate significantly decreased aortic lumen diameters and aortic external diameters of AngII-infused mice resulting in a marked reduction in AAA incidence (from 73{\%} to 29{\%}). None of these effects of diminazene aceturate were observed in the Ace2-/y mice.Conclusions-These results demonstrate that ACE2 exerts a modulatory role in AngII-induced AAA formation, and that therapeutic stimulation of ACE2 could be a benefit to reduce AAA expansion and rupture in patients with an activated renin-angiotensin system.",
keywords = "Angiotensin converting enzyme 2, Angiotensin II, Aortic aneurysms, abdominal, Hypercholesterolemia",
author = "Thatcher, {Sean E.} and Xuan Zhang and Howatt, {Deborah A.} and Frederique Yiannikouris and Susan Gurley and Terri Ennis and Curci, {John A.} and Alan Daugherty and Cassis, {Lisa A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1161/ATVBAHA.114.304613",
language = "English (US)",
volume = "34",
pages = "2617--2623",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin ii-induced abdominal aortic aneurysms

AU - Thatcher, Sean E.

AU - Zhang, Xuan

AU - Howatt, Deborah A.

AU - Yiannikouris, Frederique

AU - Gurley, Susan

AU - Ennis, Terri

AU - Curci, John A.

AU - Daugherty, Alan

AU - Cassis, Lisa A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective-Angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II (AngII) to form angiotensin-(1-7) (Ang-(1-7)), which generally opposes effects of AngII. AngII infusion into hypercholesterolemic male mice induces formation of abdominal aortic aneurysms (AAAs). This study tests the hypothesis that deficiency of ACE2 promotes AngII-induced AAAs, whereas ACE2 activation suppresses aneurysm formation.Approach and Results-ACE2 protein was detectable by immunostaining in mice and human AAAs. Whole-body deficiency of ACE2 significantly increased aortic lumen diameters and external diameters of suprarenal aortas from AngII-infused mice. Conversely, ACE2 deficiency in bone marrow-derived cells had no effect on AngII-induced AAAs. In contrast to AngII-induced AAAs, ACE2 deficiency had no significant effect on external aortic diameters of elastaseinduced AAAs. Because ACE2 deficiency promoted AAA formation in AngII-infused mice, we determined whether ACE2 activation suppressed AAAs. ACE2 activation by administration of diminazene aceturate (30 mg/kg per day) to Ldlr-/- mice increased kidney ACE2 mRNA abundance and activity and elevated plasma Ang-(1-7) concentrations. Unexpectedly, administration of diminazene aceturate significantly reduced total sera cholesterol and very low-density lipoprotein-cholesterol concentrations. Notably, diminazene aceturate significantly decreased aortic lumen diameters and aortic external diameters of AngII-infused mice resulting in a marked reduction in AAA incidence (from 73% to 29%). None of these effects of diminazene aceturate were observed in the Ace2-/y mice.Conclusions-These results demonstrate that ACE2 exerts a modulatory role in AngII-induced AAA formation, and that therapeutic stimulation of ACE2 could be a benefit to reduce AAA expansion and rupture in patients with an activated renin-angiotensin system.

AB - Objective-Angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II (AngII) to form angiotensin-(1-7) (Ang-(1-7)), which generally opposes effects of AngII. AngII infusion into hypercholesterolemic male mice induces formation of abdominal aortic aneurysms (AAAs). This study tests the hypothesis that deficiency of ACE2 promotes AngII-induced AAAs, whereas ACE2 activation suppresses aneurysm formation.Approach and Results-ACE2 protein was detectable by immunostaining in mice and human AAAs. Whole-body deficiency of ACE2 significantly increased aortic lumen diameters and external diameters of suprarenal aortas from AngII-infused mice. Conversely, ACE2 deficiency in bone marrow-derived cells had no effect on AngII-induced AAAs. In contrast to AngII-induced AAAs, ACE2 deficiency had no significant effect on external aortic diameters of elastaseinduced AAAs. Because ACE2 deficiency promoted AAA formation in AngII-infused mice, we determined whether ACE2 activation suppressed AAAs. ACE2 activation by administration of diminazene aceturate (30 mg/kg per day) to Ldlr-/- mice increased kidney ACE2 mRNA abundance and activity and elevated plasma Ang-(1-7) concentrations. Unexpectedly, administration of diminazene aceturate significantly reduced total sera cholesterol and very low-density lipoprotein-cholesterol concentrations. Notably, diminazene aceturate significantly decreased aortic lumen diameters and aortic external diameters of AngII-infused mice resulting in a marked reduction in AAA incidence (from 73% to 29%). None of these effects of diminazene aceturate were observed in the Ace2-/y mice.Conclusions-These results demonstrate that ACE2 exerts a modulatory role in AngII-induced AAA formation, and that therapeutic stimulation of ACE2 could be a benefit to reduce AAA expansion and rupture in patients with an activated renin-angiotensin system.

KW - Angiotensin converting enzyme 2

KW - Angiotensin II

KW - Aortic aneurysms, abdominal

KW - Hypercholesterolemia

UR - http://www.scopus.com/inward/record.url?scp=84918493360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918493360&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.114.304613

DO - 10.1161/ATVBAHA.114.304613

M3 - Article

C2 - 25301841

AN - SCOPUS:84918493360

VL - 34

SP - 2617

EP - 2623

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 12

ER -